Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19


The Muslim Times has the best collection of articles for the war against Covid 19, especially the vaccines.

Source: Yahoo Finance

By Jane Lanhee Lee

(Reuters) – Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds.

AbCellera has been working with pharmaceutical firm Eli Lilly and Co which is developing a coronavirus drug based on antibodies from patients that have recovered from the disease.

AbCellera uses computer vision and machine learning to quickly analyze data from human samples, and pharmaceutical clients then use that to develop drugs, AbCellera Chief Executive Carl Hansen said.

The human sample is inserted into a device the size of a credit card that has over 250,000 “chambers.” A computer checks human antibodies secreted into the chambers by sample cells to determine which has the best properties for fighting a certain disease and is worth developing, he said.

AbCellera is paid an upfront fee for the work from drug companies, and also payments for milestones of the development and eventually a small royalty as well, Hansen said.

Funds raised through AbCellera’s latest funding round will be used to hire about 100 more employees, mostly in software and data science, Hansen said, adding that the company currently has 140 employees and plans to open a new 48,000-square-foot R&D facility next year.

In addition to the latest funding round, led by venture capital firms OrbiMed and existing investor DCVC Bio, AbCellera also won a $124 million grant from the Canadian government this month to help build a manufacturing facility for antibody drug making that would help in future pandemics, said Hansen.

AbCellera said it has identified antibody candidates for drug development in diseases including cancer, immuno-oncology, pain, and metabolic disorders.


The best of the Muslim Times’ collection for war against Covid 19:

In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.

For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology

For the latest health news from BBC, Please click here

Novavax starting human trial of its vaccine in Australia

Kaiser Permanente launches first coronavirus vaccine trial

Corona Fear’s Cure: Chanting from the Bible and the Quran

Can You Chant from the Bible or the Quran to Bliss and Happiness?

Japanese flu drug ‘clearly effective’ in treating coronavirus, says China

Synthetic antibodies might offer a quick coronavirus treatment

The Four Possible Timelines for Life Returning to Normal

The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic

Coronavirus: TB Vaccination Trial Started in Melbourne, Australia

The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources

All of humanity are intimate neighbors: Coronavirus proves it once again

Praise be to God for the Miracle of Our Immune System

USA: 15-minute coronavirus test is here

Does the Ordinary Soap Kill Coronavirus?

Here’s a list of disinfectants you can use against coronavirus

For the number of cases and epidemiology in each country go to: WorldOMeters


Categories: Health, The Muslim Times

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.